| abstract |
The invention relates to a dispersible tablet, characterized in that it comprises an active phase representing at least 30% by weight of the total mass of the tablet, and an excipient phase representing at most 70% by weight of the total mass of the tablet, said active phase comprising at least in combination with paracetamol and vitamin C; said excipient phase comprising at least one disintegrant. |